User profiles for Samreen Ijaz
Samreen IjazUnit Head, Blood Borne Virus Unit, UK Health Security Agency Verified email at ukhsa.gov.uk Cited by 14484 |
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
Hepatitis e
…, R Bendall, F Legrand-Abravanel, NS Xia, S Ijaz… - The Lancet, 2012 - thelancet.com
Hepatitis E virus (HEV) was discovered during the Soviet occupation of Afghanistan in the
1980s, after an outbreak of unexplained hepatitis at a military camp. A pooled faecal extract …
1980s, after an outbreak of unexplained hepatitis at a military camp. A pooled faecal extract …
Hepatitis E: an emerging infection in developed countries
HR Dalton, R Bendall, S Ijaz, M Banks - The Lancet infectious …, 2008 - thelancet.com
Hepatitis E is endemic in many developing countries where it causes substantial morbidity.
In industrialised countries, it is considered rare, and largely confined to travellers returning …
In industrialised countries, it is considered rare, and largely confined to travellers returning …
Persistent carriage of hepatitis E virus in patients with HIV infection
To the Editor: Hepatitis E virus is an emerging infection in developed countries, with many
clinical manifestations. We describe a 48-year-old bisexual white male who was infected with …
clinical manifestations. We describe a 48-year-old bisexual white male who was infected with …
[HTML][HTML] Hepatitis E virus in blood components: a prevalence and transmission study in southeast England
PE Hewitt, S Ijaz, SR Brailsford, R Brett, S Dicks… - The Lancet, 2014 - thelancet.com
Background The prevalence of hepatitis E virus (HEV) genotype 3 infections in the English
population (including blood donors) is unknown, but is probably widespread, and the virus …
population (including blood donors) is unknown, but is probably widespread, and the virus …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
Transfusion‐transmitted hepatitis E in a 'nonhyperendemic'country
Indigenous hepatitis E is increasingly recognized in developed countries, where it may be a
zoonosis. We describe the first case of transfusion‐transmitted hepatitis E in the UK from a …
zoonosis. We describe the first case of transfusion‐transmitted hepatitis E in the UK from a …
[HTML][HTML] Hepatitis E virus and neurologic disorders
…, JM Mansuy, L Rostaing, F Keane, S Ijaz… - Emerging infectious …, 2011 - ncbi.nlm.nih.gov
Abstract Information about the spectrum of disease caused by hepatitis E virus (HEV)
genotype 3 is emerging. During 2004–2009, at 2 hospitals in the United Kingdom and France, …
genotype 3 is emerging. During 2004–2009, at 2 hospitals in the United Kingdom and France, …
[HTML][HTML] Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …
cases are urgently required to inform clinical management decisions. Methods We …
A comparison of two commercially available anti‐HEV IgG kits and a re‐evaluation of anti‐HEV IgG seroprevalence data in developed countries
R Bendall, V Ellis, S Ijaz, R Ali… - Journal of medical …, 2010 - Wiley Online Library
In developed countries, the incidence of hepatitis E virus (HEV) infection and the resulting
seroprevalence are uncertain. Published estimates of seroprevalnce in these populations …
seroprevalence are uncertain. Published estimates of seroprevalnce in these populations …